California's Adds $12 Million to its $80 Million Fight Against Lou Gehrig's Disease
Svendsen (center) and his lab team
The California stem cell agency today approved $12 million for a clinical trial aimed at finding a cure for Lou Gehrig’s disease, adding to the $80 million it has already spent on the effort.
The award for a phase one clinical trial went to Clive Svendsen at Cedars-Sinai in Los Angeles.
The agency said in a news release…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.